Catheter Precision
VTAK
6 hedge funds and large institutions have $2.77M invested in Catheter Precision in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
15% less capital invested
Capital invested by funds: $3.27M → $2.77M (-$506K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BLAM
Bourne Lent Asset Management
Pawling,
New York
|
+$305K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
-$713K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$58K |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$19K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$1K |
VTAK Hedge Fund Activity: Q4 2019 in Review
6 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q4 2019, worth a combined $2.77M — down 15% from $3.27M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new VTAK positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bourne Lent Asset Management, opening a new position worth an estimated $305K. The largest seller was BAMCO Inc, exiting entirely with an estimated $713K sold.
- 6 institutional investors held Catheter Precision (VTAK) as of Q4 2019, up from 5 in Q3 2019.
- Funds reported $2.77M of Catheter Precision stock for Q4 2019, down 15% quarter-over-quarter.
- 2 funds opened new Catheter Precision positions in Q4 2019 and 1 closed out, a net change of +1 holder.
- The largest Catheter Precision buyer in Q4 2019 was Bourne Lent Asset Management, an estimated $305K added.
- The largest Catheter Precision seller in Q4 2019 was BAMCO Inc, an estimated $713K sold.
Based on aggregated 13F filings for Q4 2019.